‡a
survivalofstage2nasopharyngealcarcinomapatientswithorwithoutconcurrentchemotherapyapropensityscorematchingstudy
‡A
Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study
‡9
1